Related references
Note: Only part of the references are listed.Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
Srinivasa Reddy Bonam et al.
NANO TODAY (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
Coronavirus 2019-nCoV: A brief perspective from the front line
Qingmei Han et al.
JOURNAL OF INFECTION (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
Paul Kellam et al.
JOURNAL OF GENERAL VIROLOGY (2020)
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Katharine H. D. Crawford et al.
VIRUSES-BASEL (2020)
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
James Brett Case et al.
CELL HOST & MICROBE (2020)
Syncytia formation by SARS-CoV-2-infected cells
Julian Buchrieser et al.
EMBO JOURNAL (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland et al.
LANCET (2020)
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
Simona Iacob et al.
FRONTIERS IN PHARMACOLOGY (2020)
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology
Rossana Bussani et al.
EBIOMEDICINE (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles
Makoto Ujike et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Role of the Spike Glycoprotein of Human Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Virus Entry and Syncytia Formation
Zhaohui Qian et al.
PLOS ONE (2013)
Correlates of Protection Induced by Vaccination
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
Shutoku Matsuyama et al.
JOURNAL OF VIROLOGY (2010)
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
Shiori Haga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Plasma membrane is the site of productive HIV-1 particle assembly
Nolwenn Jouvenet et al.
PLOS BIOLOGY (2006)
High guanine and cytosine content increases mRNA levels in mammalian cells
Grzegorz Kudla et al.
PLOS BIOLOGY (2006)
Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein
T Giroglou et al.
JOURNAL OF VIROLOGY (2004)
Codon bias and heterologous protein expression
C Gustafsson et al.
TRENDS IN BIOTECHNOLOGY (2004)
Lung pathology of severe acute respiratory syndrome (SARS): A study of 8 autopsy cases from Singapore
TJ Franks et al.
HUMAN PATHOLOGY (2003)
Share Paper
